Rheumatology, Clinical Data Quality, Osteoarthritis
8. Oct 2019
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
IMPORTANCE:
Sprifermin is under investigation as a disease-modifying osteoarthritis drug.
OBJECTIVE:
To evaluate the effects of sprifermin on changes in total femorotibial joint cartilage thickness in the more symptomatic knee of patients with osteoarthritis.
DESIGN, SETTING, AND PARTICIPANT…
Read the publication
Journal:
Authors:
- Hochberg MC,
- Guermazi A,
- Guehring H,
- Aydemir A,
- Wax S,
- Fleuranceau-Morel P,
- Reinstrup Bihlet A,
- Byrjalsen I,
- Ragnar Andersen J,
- Eckstein F,